Human granulocyte colony-stimulating factor (GCSF) is a 19 kDa cytokine that is approved by the US FDA for the treatment of neutropenia patients due to its ability to control the production, differentiation and function of granulocytes1, 2. The gene discussed is CSF3; the disease is neutropenia.